Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Genovac Logo
Genovac Growth Score
79
CB Rank
938219
Heat Score
38
Genovac offers a unique combination of the most advanced antibody discovery tools.
Founded
obfuscation
Private Fargo, North Dakota, United States101-250 genovac.com
Biotechnology
Overview

Genovac
Growth Score
79
Heat Score
38

Growth Score79
-6 pts
in past quarter
Heat Score 38
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Genovac

CB Rank
938219
Genovac offers a unique combination of the most advanced antibody discovery tools.
Founded
obfuscation
Private Fargo, North Dakota, United States101-250 genovac.com
Biotechnology

Key People

  • Photo of Brian Walters
    Brian Walters: Chief Executive Officer
    Past Role: Aldevron, President, Antibody Business Unit

Details

Operating Status Active
Company Type For Profit
About the Company
Genovac offers a unique combination of the most advanced antibody discovery tools. Genovac innovative immunization technologies, single B cell screening platforms, and multiple species options position it to deliver success against challenging targets. Genovac offers clients everything from cDNA synthesis to large-scale antibody production.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Genetic Immunization Technology
A method to develop antibodies directly from DNA sequences or accession numbers without requiring purified proteins.
Single B Cell Screening Platforms
Automated platforms for isolating rare antibodies from individual B cells using technologies like Berkeley Lights Beacon and 10X Genomics ChromiumX.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 1 Contacts 18

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

85
-41.38%
 in past month

IT Spend

$572.6KThis year, Genovac is projected to spend $572.6K on IT, according to Aberdeen.

Active Website Tech Count

9Genovac is actively using 9 technologies for its website, according to BuiltWith. These include U.S. Server Location, Person Schema, and  Gravatar Profiles.

Total IP

6Genovac has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Genovac has registered 5 trademarks with the most popular class being 'Scientific and technological services', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Genovac's headquarters? Genovac is located in Fargo, North Dakota, United States.Who are Genovac's competitors? Alternatives and possible competitors to Genovac may include Biointron, Syngene, and  LakePharma.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|